In consistent with these reports, miR-125b was found to exert its anti-tumor activity via regulating ENPEP (aminopeptidase A), CK2-α (casein kinase 2 alpha), CCNJ (cyclin J) and MEGF9 (multiple EGF-like-domains 9) in breast cancer [29]. This evidence concerns the gene MEGF9 and breast carcinoma.